Hospitalizations in patients with atrial fibrillation: an analysis from ROCKET AF.

ABSTRACT:

Aims

The high costs associated with treatment for atrial fibrillation (AF) are primarily due to hospital care, but there are limited data to understand the reasons for and predictors of hospitalization in patients with AF.

Methods and results

The ROCKET AF trial compared rivaroxaban with warfarin for stroke prophylaxis in AF. We described the frequency of and reasons for hospitalization during study follow-up and utilized Cox proportional hazards models to assess for baseline characteristics associated with all-cause hospitalization. Of 14 171 patients, 14% were hospitalized at least once. Of 2614 total hospitalizations, 41% were cardiovascular including 4% for AF; of the remaining, 12% were for bleeding. Compared with patients not hospitalized, hospitalized patients were ol

SUBMITTER: DeVore AD 

PROVIDER: S-EPMC4974633 | biostudies-literature | 2016 Aug

REPOSITORIES: biostudies-literature